Logo image of HDL

SUPER HI INTERNATIONAL HOLDI (HDL) Stock Fundamental Analysis

NASDAQ:HDL - Nasdaq - US86803S1069 - ADR - Currency: USD

20.41  -0.03 (-0.15%)

Fundamental Rating

4

HDL gets a fundamental rating of 4 out of 10. The analysis compared the fundamentals against 133 industry peers in the Hotels, Restaurants & Leisure industry. HDL has an average financial health and profitability rating. HDL is valied quite expensively at the moment, while it does show a decent growth rate.


Dividend Valuation Growth Profitability Health

Quickly go to:

4

1. Profitability

1.1 Basic Checks

HDL had positive earnings in the past year.
In multiple years HDL reported negative net income over the last 5 years.
In multiple years HDL reported negative operating cash flow during the last 5 years.
HDL Yearly Net Income VS EBIT VS OCF VS FCFHDL Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2020 2021 2022 2023 2024 0 50M -50M 100M -100M -150M

1.2 Ratios

HDL has a Return On Assets (3.19%) which is in line with its industry peers.
With a decent Return On Equity value of 6.06%, HDL is doing good in the industry, outperforming 63.16% of the companies in the same industry.
HDL has a Return On Invested Capital (5.60%) which is comparable to the rest of the industry.
HDL had an Average Return On Invested Capital over the past 3 years of 4.49%. This is significantly below the industry average of 13.97%.
The last Return On Invested Capital (5.60%) for HDL is above the 3 year average (4.49%), which is a sign of increasing profitability.
Industry RankSector Rank
ROA 3.19%
ROE 6.06%
ROIC 5.6%
ROA(3y)0.16%
ROA(5y)-6.5%
ROE(3y)-0.55%
ROE(5y)N/A
ROIC(3y)4.49%
ROIC(5y)N/A
HDL Yearly ROA, ROE, ROICHDL Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2020 2021 2022 2023 2024 0 50 -50 -100 -150

1.3 Margins

Looking at the Profit Margin, with a value of 2.80%, HDL is in line with its industry, outperforming 48.87% of the companies in the same industry.
With a Operating Margin value of 5.68%, HDL is not doing good in the industry: 61.65% of the companies in the same industry are doing better.
HDL has a better Gross Margin (66.89%) than 79.70% of its industry peers.
In the last couple of years the Gross Margin of HDL has grown nicely.
Industry RankSector Rank
OM 5.68%
PM (TTM) 2.8%
GM 66.89%
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y1.7%
GM growth 5YN/A
HDL Yearly Profit, Operating, Gross MarginsHDL Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2020 2021 2022 2023 2024 0 20 -20 40 -40 60

More info and screens

6

2. Health

2.1 Basic Checks

HDL has a Return on Invested Capital (ROIC), which is below the Cost of Capital (WACC), which means it is destroying value.
Compared to 1 year ago, HDL has more shares outstanding
The debt/assets ratio for HDL has been reduced compared to a year ago.
HDL Yearly Shares OutstandingHDL Yearly Shares OutstandingYearly Shares Outstanding 2020 2021 2022 2023 2024 20M 40M 60M
HDL Yearly Total Debt VS Total AssetsHDL Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2020 2021 2022 2023 2024 200M 400M 600M

2.2 Solvency

HDL has an Altman-Z score of 3.53. This indicates that HDL is financially healthy and has little risk of bankruptcy at the moment.
The Altman-Z score of HDL (3.53) is better than 78.95% of its industry peers.
HDL has a Debt/Equity ratio of 0.48. This is a healthy value indicating a solid balance between debt and equity.
HDL has a better Debt to Equity ratio (0.48) than 71.43% of its industry peers.
Industry RankSector Rank
Debt/Equity 0.48
Debt/FCF N/A
Altman-Z 3.53
ROIC/WACC0.62
WACC9.03%
HDL Yearly LT Debt VS Equity VS FCFHDL Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2020 2021 2022 2023 2024 0 100M -100M 200M 300M

2.3 Liquidity

A Current Ratio of 2.51 indicates that HDL has no problem at all paying its short term obligations.
HDL has a Current ratio of 2.51. This is amongst the best in the industry. HDL outperforms 90.98% of its industry peers.
HDL has a Quick Ratio of 2.27. This indicates that HDL is financially healthy and has no problem in meeting its short term obligations.
With an excellent Quick ratio value of 2.27, HDL belongs to the best of the industry, outperforming 88.72% of the companies in the same industry.
Industry RankSector Rank
Current Ratio 2.51
Quick Ratio 2.27
HDL Yearly Current Assets VS Current LiabilitesHDL Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2020 2021 2022 2023 2024 100M 200M 300M 400M 500M

More info and screens

6

3. Growth

3.1 Past

The earnings per share for HDL have decreased strongly by -13.04% in the last year.
The Revenue has grown by 13.40% in the past year. This is quite good.
HDL shows a strong growth in Revenue. Measured over the last years, the Revenue has been growing by 35.57% yearly.
EPS 1Y (TTM)-13.04%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%-150.38%
Revenue 1Y (TTM)13.4%
Revenue growth 3Y35.57%
Revenue growth 5YN/A
Sales Q2Q%-42.4%

3.2 Future

Based on estimates for the next years, HDL will show a very strong growth in Earnings Per Share. The EPS will grow by 20.74% on average per year.
Based on estimates for the next years, HDL will show a quite strong growth in Revenue. The Revenue will grow by 12.56% on average per year.
EPS Next Y28%
EPS Next 2Y26.49%
EPS Next 3Y20.74%
EPS Next 5YN/A
Revenue Next Year12.27%
Revenue Next 2Y12.79%
Revenue Next 3Y12.56%
Revenue Next 5YN/A

3.3 Evolution

Although the future Revenue growth is still strong, it is not able to hold up the even more excellent growth rate of the past years.
HDL Yearly Revenue VS EstimatesHDL Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2020 2021 2022 2023 2024 2025 2026 2027 200M 400M 600M 800M 1B
HDL Yearly EPS VS EstimatesHDL Yearly EPS VS EstimatesYearly EPS VS Estimates 2022 2023 2024 2025 2026 2027 0 0.5 -0.5 1

More info and screens

1

4. Valuation

4.1 Price/Earnings Ratio

A Price/Earnings ratio of 52.33 indicates a quite expensive valuation of HDL.
HDL's Price/Earnings is on the same level as the industry average.
Compared to an average S&P500 Price/Earnings ratio of 26.52, HDL is valued quite expensively.
A Price/Forward Earnings ratio of 25.95 indicates a quite expensive valuation of HDL.
The rest of the industry has a similar Price/Forward Earnings ratio as HDL.
Compared to an average S&P500 Price/Forward Earnings ratio of 22.25, HDL is valued at the same level.
Industry RankSector Rank
PE 52.33
Fwd PE 25.95
HDL Price Earnings VS Forward Price EarningsHDL Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 10 20 30 40 50

4.2 Price Multiples

Industry RankSector Rank
P/FCF N/A
EV/EBITDA N/A
HDL Per share dataHDL EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 2 4 6 8 10

4.3 Compensation for Growth

The high PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates an expensive valuation of the company.
HDL's earnings are expected to grow with 20.74% in the coming years. This may justify a more expensive valuation.
PEG (NY)1.87
PEG (5Y)N/A
EPS Next 2Y26.49%
EPS Next 3Y20.74%

More info and screens

0

5. Dividend

5.1 Amount

No dividends for HDL!.
Industry RankSector Rank
Dividend Yield N/A

More info and screens

SUPER HI INTERNATIONAL HOLDI

NASDAQ:HDL (6/6/2025, 8:00:01 PM)

20.41

-0.03 (-0.15%)

Chartmill FA Rating
GICS SectorConsumer Discretionary
GICS IndustryGroupConsumer Services
GICS IndustryHotels, Restaurants & Leisure
Earnings (Last)03-25 2025-03-25/bmo
Earnings (Next)N/A N/A
Inst Owners2.68%
Inst Owner Change-12.77%
Ins Owners0.06%
Ins Owner ChangeN/A
Market Cap1.20B
Analysts83.64
Price Target21.11 (3.43%)
Short Float %0.04%
Short Ratio2.38
Dividend
Industry RankSector Rank
Dividend Yield N/A
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)N/A
Avg EPS beat(2)N/A
Min EPS beat(2)N/A
Max EPS beat(2)N/A
EPS beat(4)N/A
Avg EPS beat(4)N/A
Min EPS beat(4)N/A
Max EPS beat(4)N/A
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)N/A
Avg Revenue beat(2)N/A
Min Revenue beat(2)N/A
Max Revenue beat(2)N/A
Revenue beat(4)N/A
Avg Revenue beat(4)N/A
Min Revenue beat(4)N/A
Max Revenue beat(4)N/A
Revenue beat(8)N/A
Avg Revenue beat(8)N/A
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)1.06%
PT rev (3m)-12.63%
EPS NQ rev (1m)N/A
EPS NQ rev (3m)N/A
EPS NY rev (1m)0%
EPS NY rev (3m)-3.1%
Revenue NQ rev (1m)N/A
Revenue NQ rev (3m)N/A
Revenue NY rev (1m)0%
Revenue NY rev (3m)-1.59%
Valuation
Industry RankSector Rank
PE 52.33
Fwd PE 25.95
P/S 1.54
P/FCF N/A
P/OCF N/A
P/B 3.34
P/tB 3.34
EV/EBITDA N/A
EPS(TTM)0.39
EY1.91%
EPS(NY)0.79
Fwd EY3.85%
FCF(TTM)N/A
FCFYN/A
OCF(TTM)N/A
OCFYN/A
SpS13.23
BVpS6.12
TBVpS6.11
PEG (NY)1.87
PEG (5Y)N/A
Profitability
Industry RankSector Rank
ROA 3.19%
ROE 6.06%
ROCE 7.96%
ROIC 5.6%
ROICexc 10.33%
ROICexgc 10.34%
OM 5.68%
PM (TTM) 2.8%
GM 66.89%
FCFM N/A
ROA(3y)0.16%
ROA(5y)-6.5%
ROE(3y)-0.55%
ROE(5y)N/A
ROIC(3y)4.49%
ROIC(5y)N/A
ROICexc(3y)7.24%
ROICexc(5y)N/A
ROICexgc(3y)7.25%
ROICexgc(5y)N/A
ROCE(3y)6.38%
ROCE(5y)N/A
ROICexcg growth 3YN/A
ROICexcg growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y1.7%
GM growth 5YN/A
F-ScoreN/A
Asset Turnover1.14
Health
Industry RankSector Rank
Debt/Equity 0.48
Debt/FCF N/A
Debt/EBITDA N/A
Cap/Depr N/A
Cap/Sales N/A
Interest Coverage N/A
Cash Conversion N/A
Profit Quality N/A
Current Ratio 2.51
Quick Ratio 2.27
Altman-Z 3.53
F-ScoreN/A
WACC9.03%
ROIC/WACC0.62
Cap/Depr(3y)N/A
Cap/Depr(5y)N/A
Cap/Sales(3y)N/A
Cap/Sales(5y)N/A
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)-13.04%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%-150.38%
EPS Next Y28%
EPS Next 2Y26.49%
EPS Next 3Y20.74%
EPS Next 5YN/A
Revenue 1Y (TTM)13.4%
Revenue growth 3Y35.57%
Revenue growth 5YN/A
Sales Q2Q%-42.4%
Revenue Next Year12.27%
Revenue Next 2Y12.79%
Revenue Next 3Y12.56%
Revenue Next 5YN/A
EBIT growth 1Y20.03%
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next Year217.06%
EBIT Next 3Y61.38%
EBIT Next 5YN/A
FCF growth 1YN/A
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1YN/A
OCF growth 3YN/A
OCF growth 5YN/A